WithdrawnNot Applicable

Testosterone Gel in Poor Responders Undergoing IVF

Vietnam0Started 2015-09

Plain-language summary

The main purpose of this study is to compare the number of oocytes retrieved after using transdermal testosterone gel 10 mg per day or Dehydroepiandrosterone (DHEA) 75mg per day for 6-8 weeks as pre-treatment for poor ovarian responders undergoing in-vitro fertilization (IVF).

Who can participate

Age range18 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: To be eligible for enrolment into this trial, each female subject must fulfill all of the following criteria at the start of enrolment, unless specified otherwise: * Had one or two previous failure IVF cycle, using GnRH antagonist protocol (≥ 300 IU FSH/hMG per day) and the number of retrieved oocytes are ≤ 3; * Antral follicle counts (AFC) \< 6 or Anti-Mullerian Hormone (AMH) \< 1.26 ng/ml Exclusion Criteria: To be eligible for enrolment in this study each subject must not meet any of the following criteria: * Oocyte donation cycle * Patients have thyroid disease * Patients have liver or kidney dysfunction * Patients have abnormal puberty or genital development. * Patients have previous surgery on ovaries

What they're measuring

Number of oocytes

Timeframe: 30 minutes after oocyte retrieval completed

Trial details

NCT IDNCT02549690

SponsorVietnam National University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Infertility trials